CORONAVIRUS (COVID-19) RESOURCE CENTER Read More

Tackling Opioid Use Disorder as part of Routine Prenatal Care in a Local Health Department

State: FL Type: Model Practice Year: 2023

Citrus County is a medium sized rural county in the state of Florida. It has a population of approximately 155,000, with over half of the population over the age of 55 years old. There are approximately 1,100 births per year. Citrus county is 93% White Non-Hispanic. There is 1 hospital with a delivery unit and currently no NICU's in the county. There are only 2 practices that see obstetric patients in the county. In 2017 Florida Dept of Health in Citrus County (FDOH-Citrus), as well as community members, noticed an increase of pregnant people with substance use disorder (SUD). With the increase they also noticed health issues that compounded the problem such as poor birth outcomes like neonatal abstinence syndrome, still births, poor breastfeeding and more. In addition, the poor birth outcomes barriers to care were common in the county. In 2018, a retrospective study of 201 DOH-Citrus pregnant patients was conducted. All patients received a drug screen at their initial prenatal visit. Out of 201, 76 (38%) tested positive for controlled substances. Nicotine and alcohol were not included in the screenings. Citrus county lacked a provider that would offer SUD treatment while pregnant even when attempts to coordinate prenatal care and SUD treatment.  

FDOH-Citrus offered prenatal care to over 300 pregnant people annually as part of their services for the community. Within the prenatal care program all new patients are given a urine drug screen (UDS). Pregnant people that had a positive UDS they were referred out for SUD treatment while FDOH-Citrus continued to provide prenatal care. The American College of Obstetricians and Gynecologists (ACOG) has recommended opioid agonist pharmacotherapy, or MAT as the recommended therapy for pregnant people with an opioid use disorder (OUD). This provided many issues for those that became pregnant in need of medicated assisted treatment (MAT) since they had to travel out of county and could lead to treatment being several hours away. Also, newly pregnant people that were currently getting MAT would be dismissed from their treatment program as MAT providers in the county would not treat pregnant people. Other prenatal care providers in the county would also dismiss pregnant people from there care if they would find to have a positive UDS or admitted to substance use. 

In 2018, with an increase of community support, FDOH Citrus started looking into options for treatment within county. At the same time federal regulations expanded for Certified Nurse-Midwifes (CNM) to allow subscribing power for MAT. FDOH-Citrus CNM took training in 2019 to provide MAT for pregnant people receiving prenatal care and needing treatment for SUD. Programmatic concerns had to be addressed as to what was within the guidelines of treatment for FDOH-Citrus prenatal care program. Concerns about FDOH-Citrus becoming a MAT clinic that had a different connotation associated with what services are offered and how it could be perceived by the public. Clear partnerships had to be developed for mental health treatment along MAT through the prenatal care program to avoid confusion as to services provided.  

FDOH-Citrus had to overcome several obstacles such as community and legal perceptions of services that were being offered. FDOH-Citrus actively worked to address stigma of SUD within the department and educate staff as to why non bias treatment was needed. In addition, issues with billing and services provided had to be addressed. Prenatal care and MAT services had to be scheduled on different days to avoid confusion of services and double billing.  

In 2019, Citrus County had a new behavioral health provider and FDOH-Citrus was able to build a relationship that would offer mental health support to pregnant people getting MAT treatment. With the support of leadership, community programs like the Substance Exposed Newborn (SEN) Task Force and local mental health provider pregnant people began receiving MAT, buprenorphine, in 2020 as well as their prenatal care in one place.  

In 2020 FDOH-Citrus had 8 pregnant people enter prenatal care and received MAT, reducing barriers to care and increasing continuity. With the additional burdens that 2020 had due to COVID-19, FDOH-Citrus continued to adapt, support and worked to reduce barriers. In 2021, there were a total of 9 pregnant people that received MAT and prenatal care at FDOH-Citrus. In 2022 FDOH-Citrus continued to grow with over 11 pregnant people receiving prenatal care and MAT. 

To this day FDOH-Citrus is the only known health department in Florida that provides MAT to patients getting prenatal care.

FDOH-Citrus offered prenatal care to over 300 pregnant people annually as part of their services for the community. FDOH-Citrus is one of two obstetric clinics in the county. The other obstetric clinic refers all pregnant people with substance use disorder (SUD) to FDOH-Citrus for prenatal care as they are not able to provide care for that demographic. In 2017 the FDOH-Citrus OB provider attended a summit on Neonatal Abstinence Syndrome. There was also a Healthy Babies initiative that gained community engagement due to the ongoing and rising overdose and substance use issues in the county. Referrals of pregnant people with SUD started long before FDOH-Citrus was ever able to meet the needs for treatment of SUD.

In 2018, a retrospective study of 201 DOH-Citrus pregnant patients was conducted. All patients received a drug screen at their initial prenatal visit. Out of 201, 76 (38%) tested positive for controlled substances. Nicotine and alcohol were not included in the screenings. After the retrospective study was conducted the Citrus SEN Task Force was formed. The Citrus County Substance Exposed Newborn Taskforce (Citrus SEN) began in 2018 in alignment with the Circuit 5 SEN Taskforce with the purpose of addressing the unique needs of substance exposed newborns in Citrus County. The Citrus SEN Taskforce is a collaborative group comprised of agency representatives from those providing prevention and services to expectant families of newborns. In 2018, with an increase of community support, FDOH Citrus started looking into options for treatment within county. In the past clients that tested positive for substances were referred out of county. This was not a sustainable practice, as Citrus County is a rural county with limited resources for public transit. Most of these clients were also low-income, so leaving the county for medical services on a weekly basis was not an attainable outcome. This also often left them having to pick between getting to a prenatal appointment or an medicated assisted treatment (MAT) appointment.

At the time federal regulations expanded for Certified Nurse-Midwifes (CNM) to allow subscribing power for MAT. FDOH-Citrus CNM took training in 2019 to provide MAT for pregnant people receiving prenatal care and needing treatment for SUD. In 2019, mental health providers were engaged and educated on SUD and options for treatment. The Citrus-DOH OB provider obtained certification to treat SUD. Citrus-DOH works with Lifestream to coordinate care of behavioral health and peer support a key component to sustaining SUD recovery. The first patient for the program was seen in 2020.

This practice addresses health inequities in our jurisdiction by providing SUD treatment to prenatal clients, where services were not provided before. This addresses the health inequities by giving access to high-quality and affordable healthcare services.

The target population to be served is all women of childbearing age in the community, and the extended families faced with caring for a SEN newborn. Substance use during pregnancy is a complex public health problem often resulting in multiple consequences for a woman and her newborn. Nicotine, alcohol, cocaine, hallucinogens' including marijuana, prescription or nonprescription narcotic/opioids, and certain non-narcotic medications during pregnancy may result in adverse effects on the health and well-being of the newborn. Education of the providers in the Citrus County community will lead to accurate and consistent diagnoses of exposed births allowing for early intervention services for the newborn and mother. These services are critical in minimizing the acute and long-term effects of prenatal substance exposure.

FDOH-Citrus had to overcome several obstacles to like community and legal perceptions of services that were being offered. FDOH-Citrus actively worked to address stigma of SUD within the department and educate staff as to why non-biases treatment was needed. In addition, issues with billing and services provided had to be addressed. 

In the process of developing this program Programmatic concerns had to be addressed, there were concerns about the connotation associated with DOH-Citrus becoming a clinic that provided various MAT services and how this could be perceived by the public. DOH-Citrus had to clarify what was within the practice guidelines regarding medication treatment for those receiving prenatal care within the department. To avoid confusion around what services DOH-Citrus offered, clear distinctions had to be made. DOH-Citrus relayed that they were not providers of MAT to anyone within the community, and that the program only incorporated MAT for pregnant clients struggling with SUD who also needed concurrent prenatal care. DOH-Citrus framed perinatal SUD as a health condition requiring a medical diagnosis, similar to how other physical conditions would be assessed. By approaching clients as obstetric patients requiring treatment for a medical condition, offering concurrent prenatal care and MAT became the prescribed standard of care for a pregnant person with SUD. Ensuring that MAT is included in the standard prenatal care has been critical for sustaining this program, as this program is funded solely by the patient's health insurance. This approach not only reduces barriers to care by providing lifesaving treatment and necessary prenatal care jointly, but it also helps to reduce stigma around perinatal substance use that often limits access to care.

Initially, this program was thought to reach approximately 5 pregnant people a year. In less than 3 years almost 30 pregnant people have worked with the program, some even coming from other counties as the same options were not available to them locally. Since the program's inception, the positive outcomes with the pregnant people we hope to encourage more to address SUD in their prenatal program. Along with published papers and education through national conferences, FDOH-Citrus is hopeful that this program will reach a much higher number and hopefully be implemented in many other local small prenatal clinics. Thus, reducing the stigma and barriers to healthier pregnancies, deliveries and babies.

This current practice is innovative as it is the only health department within the state of Florida to offer MAT treatment to prenatal clients. MAT treatment for prenatal clients is not new to the field of public health, however it is uncommon and pregnant people often deal with added barriers and stigma. There is little to no data on substance use during pregnancy, which makes it difficult to justify needs to new programs.

A focus group of FDOH-Citrus OB patients was conducted in partnership with Florida State University (FSU) providing further qualitative feedback. The Citrus County Prenatal Program Participant Focus Group is a feature of Strategy 5 within the Overdose Data to Action (OD2A) initiative which is funded by the Centers for Disease Control and Prevention (CDC) and administered by the Florida Department of Health (FDOH). The focus group was a way for FDOH-Citrus to learn more about the barriers to receiving prenatal care, They're just they're so coldhearted, (other area OB provider). It's just I don't know why they do not communicate with the health department, or they don't reassure women that there's help. Why is it stopping you from telling a person who is hooked on heroin or opiates or whatever that, ‘Hey, listen, there's this program and we're gonna help you.' What stops them from doing it? Why did that lady that day on the phone was telling me basically, ‘Hey, you're a piece of crap, and we can't take care of you.' And hang up on the phone. I mean, I just I don't get it. It really blows my mind how coldhearted someone could be, especially knowing a woman in the beginning of your pregnancy, your hormones are everywhere on top of going through an addiction.”

In 2017, nearly 70% of Citrus County's births were covered by the state's Medicaid program (Florida DOH, 2020). That same year, DOH-Citrus and community members noticed an increase in SUD among the pregnant population. They also observed fetal deaths attributed to congenital abnormalities and other poor birth outcomes including neonatal abstinence syndrome (NAS), stillbirths, suboptimal breastfeeding, and other complications. To address the disparities around perinatal SUD in the county, dedicated staff from the county health department, home visiting services, sheriff department, and Department of Children and Families came together to establish the Citrus Substance Exposed Newborn (Citrus-SEN) Task Force. The Stakeholders for the creation of Citrus-SEN were Healthy start, Healthy Families, local Sheriff's Department, Pregnancy Centers, Citrus Memorial Hospital, FDOH-Citrus, Surrounding area hospitals, Department of Children and Families, Lifestream Behavioral Health, Casa, Anti-Drug Coalition of Citrus County, Citrus County Drug Court, The Centers, Bayfront Seven Rivers, local Obstetrical offices, WIC, and Circuit 5 SEN.  

In 2018, the Citrus County SEN Taskforce was developed to address issues that contribute to high rates of SEN seen in the county. This Taskforce was developed with other local counties to pull resources and education. The FDOH-Citrus IBCLC being a point of contact through the work done with the Florida Healthy Babies Program. Being able to share information with other SEN Taskforces in neighboring counties highlighted the lack of resources for pregnant people with SUD. While working to decrease stigma and addressing issues and barriers not commonly understood when working with SEN families. 

The objective of the Citrus-SEN Taskforce for this grant is to raise awareness in Citrus County about the risk associated with the use of substances during pregnancy with the goal of preventing addiction in all women of reproductive age, as well as assessing and treating any unhealthy use prior to conception. Healthy Families took a lead role in partnership with FDOH-Citrus obtaining a grant that provides resources directly to families affected by SUD.

Through the FDOH-Citrus and Florida West Coast Breastfeeding Task Force (FLWCBTF) partnership, a reference book on the effects of medications on breastmilk was shared with local healthcare providers in 2019 and redistributed every 2 years. The book Medications and Mothers Milk by Dr. Hale supports prescribers to reference updated information to support MAT while breastfeeding, as a common misunderstanding reported by mothers was that they needed to stop breastfeeding due to the use of medication to treat their SUD. Additionally, staff and community members that work across these two organizations have been able to attend events and represent both FDOH-Citrus and FLWCBTF providing a greater continuity of breastfeeding support prenatally and after baby was born.

In 2019, DOH-Citrus partnered with the community's not-for-profit behavioral health care center, LifeStream, which is the local entity that provides mental health services to the uninsured and underinsured within the county. As DOH-Citrus does not offer behavioral health services of any kind, LifeStream has been able to fill this gap by offering mental health counseling to pregnant clients receiving prenatal care through the department. This partnership has allowed the health department to provide holistic prenatal care to treat SUD among pregnant clients. The process of receiving MAT and a referral to LifeStream for mental health counseling for SUD begins as soon as a patient presents for care and agrees to the assistance offered through the program, which takes place during their scheduled obstetrical appointment. All services take place at the health department, allowing clients to receive all their care on the same day and location. Patients are provided prenatal care until six weeks postpartum. After the final postpartum appointment, MAT care is transferred to LifeStream for the continuation of their MAT needs.

With the support of FDOH-Citrus leadership, community programs like the Substance Exposed Newborn (SEN) Task Force and local mental health provider pregnant people began receiving MAT, buprenorphine, in 2020 as well as their prenatal care in one place.

Citrus-SEN meets bi-monthly so that community stakeholders are able to bring new issues to the group. They address the prenatal care and MAT as well as projects that may benefit the community. Members of the Citrus-SEN are also members of the Citrus Opioid Taskforce as well as other county SEN taskforces. This helps to bring continuity within the community and neighboring counties that lack the same program.  

FDOH-Citrus is part of the Florida Maternal Mental Health Collaborative (FLMMHC) and Florida BH Impact. The Florida BH IMPACT Program is an innovative initiative by the Florida Department of Health (DOH), the Florida State University (FSU) College of Medicine and the FLMMHC.  This program's goal is to improve the identification and treatment of pregnant and postpartum women who experience mental health and substance abuse disorders. They aim to promote maternal and child health by building the capacity of health care providers for addressing these critical issues through professional development, expert consultation and support, and dissemination of best practices.

Substance use disorder in pregnancy is not tracked outside of the local health department. There is other data related to SEN that can be viewed in programs from FLHealthCharts that can correlate with SUD, however. The main methods that were used to collect data were medical documents and records. Quantitative and Qualitative methods were both used in the evaluation process. These methods were selected as it is important to have quantitative data for the purpose of evaluation. Mixed methods were used to conceptualize a fuller understanding of clients of the program. If other counties in the state of Florida will use this program, they need to be able to see firsthand the efficacy and positive outcomes.  The Qualitative methods included the Florida State University Focus Groups that were conducted.

The data was located throughout a few different software programs, both internal and external. External programs that data was collected from included Quest Diagnostics and LabCorp. Internal programs include HMS, in house created spreadsheets, and FLWise. 

The evaluation viewed many different areas of the program including but not limited to patient demographics (age, sex, ethnicity, race, home address, highest level of education, marital status), how many previous pregnancies, insurance providers, drug screen results from initial drug screens and any relapse screens, and participation in WIC.

ARC PRo was used to create geographic heat maps of patient addresses. This heat map will assist the program by showing them where clusters of clients are. The program will be able to use the map as a resource for future outreach, promotion and advertising of the program. This map was compared to overdose heat maps for the county. It was found that the clusters bore a strong resemblance in both maps. This helps staff to conclude that the patients are living in areas with higher rates of fatal and non-fatal drug overdoses.

The evaluation also helped staff to understand the average client better. It was found that 70% of clients identify as single for their marital status, 61% stated high school degree as their highest level of education attained, 96% of clients are on Medicaid, none identified as a Veteran, and only .5% identified as Hispanic. These findings do correlate with the average demographics of Citrus County.

It was also found that a majority of clients were on their 3rd pregnancy. Through this finding the staff realized they needed to investigate this area further to answer some of the following questions: did the clients use substances throughout the earlier pregnancies and just not get tested? Did the clients not develop substance use disorder until the 3rd pregnancy? Were clients not ready for the program until the 3rd pregnancy? This information also helps guide research in this works in the field.

The evaluation of drug screens also created a clearer picture on which type of substance users the clients were. The three highest percentages of positive drug screens outside of opioids were as follows: 35% tested positive for Amphetamines, 22% tested positive for Marijuana, and 17% tested positive for Methamphetamines.

Through the evaluation process of insurance billing and coding it was discovered that it was being done improperly. Staff were not coding for MAT visits due to the fact if they coded for both MAT and prenatal only MAT was reimbursed. Since MAT reimbursed at a lower rate, staff made the decision to only code for prenatal on days that both MAT and prenatal visits occurred. Since this was discovered, staff were educated on the importance medical coding provides towards data collection.

A focus group of FDOH-Citrus OB patients was conducted in partnership with Florida State University (FSU) providing further qualitative feedback. The Citrus County Prenatal Program Participant Focus Group is a feature of Strategy 5 within the Overdose Data to Action (OD2A) initiative which is funded by the Centers for Disease Control and Prevention (CDC) and administered by the Florida Department of Health (FDOH).

The focus group was a way for FDOH-Citrus to learn from those that had completed their OB care and those currently pregnant getting MAT support. Quotes from the focus group gave information on what is being done right and where to improve like If it wasn't for (providers name) and the staff back there and LifeStream and everything, I wouldn't know where I would be right now. So, it's made me feel stronger as a person to be like, ‘Yes, I'm on this medication, but I am not ashamed. And I will not let anyone make me feel any lower of myself.' I won't be." Or One of the ladies… makes the appointments...I sat on the phone, and I cried to her. I bawled my eyes out when I knew that everything was gonna be okay. It just it was weight off my shoulders. I was like, ‘I'm able to breathe now.' Like, ‘You're gonna be okay. You're gonna get through this. You're gonna get on the right medication, and your baby's gonna be fine. You're gonna be fine. Your mental health's gonna be okay.'” The focus group also allowed for feedback on need to raise awareness of the program like this participate stated The doctors need more information, and the other ideas were great too. Facebook, pamphlets, billboards, anything, conventions. Those are great ideas. Billboard, pamphlets at the doctor's office. Just letting the doctors [be] aware so they can say something to people. If they have someone like I did, like women who were pregnant and needed help instead of just turning the cold shoulder to them they actually say, ‘Hey, we got this information. Let's see if we can get you over there or something.'"

Fiscal challenges are not the pressing concern for this program as the majority of the pregnant people seen for SUD are on Medicaid. The treatment recommendations from ACOG have recommended opioid agonist pharmacotherapy, or MAT as the recommended therapy for pregnant people with an opioid use disorder (OUD) allows for billing of pregnant people are seen for prenatal checks at each appointment.

This program is limited in the lack of obstetrical providers that are willing to work with pregnant people with SUD. Reducing stigma and increasing education for the treatment of SUD in pregnant people is one way to combat these issues. Highlighting things like the focus group and what pregnant people with disease of SUD want, I just wanted what was… best for the baby. What to do that would make the baby the healthiest, and what it needed to just be the best it can be. That basic way that I was gonna get the correct treatment. My main thing of coming to here and getting through the program was I wanted to learn. I wanted to learn about how I'm gonna get through this, what are my options.”

To ensure SUD in the prenatal care program at FDOH-Citrus is a continued focus substance use screening is part of the county's strategic plan. This goal was added at the end of 2021, increase the use of evidence-based, interview substance use screening for pregnant people entering DOH-Citrus prenatal care program.” Behavioral Health is part of the county's Community Health Improvement Partnership (CHIP) and addresses the need for MAT in the community as well as for pregnant people.

FDOH-Citrus prenatal care has collaborated with Florida CORE (Coordinated Opioid Recovery) program to effectively sustain the availability of services and continue to provide services for healthy maternal and infant outcomes within Citrus County. CORE is partnering to implement a network of addiction care in up to 12 counties in Florida, with Citrus County being part of its second phase. With the collaboration of CORE, additional funds will be available to the SUD prenatal program. Additional funding will allow for sustainability for the program. The Substance Exposed Newborn Taskforce continues to meet on a bi-monthly basis with increased interest from new stakeholders each month. There are currently 20 members from throughout the community.

FDOH-Citrus' CORE program is working with the Citrus County Opioid Task Force and local fire rescue. CORE will provide integrated response to opioid overdose with treatment. This will add another layer of referrals to pregnant people dealing with SUD. Providing judgement free support in the community to encourage usage of prenatal care and treatment of SUD.

 

Resources:

1. United States Department of Health and Human Services, Substance Abuse and Mental Health Services Administration. (2020). National Survey on Drug Use and Health: Women. https://www.samhsa.gov/data/sites/default/files/reports/rpt31102/2019NSDUHWomen/Women%202019%20NSDUH.pdf 2. Forray, A., Foster, D. (2015). Substance use in the perinatal period. Current Psychiatry Reports, 17, 91. https://doi.org/10.1007/s11920-015-0626-5 3. Jarlenski, M., Hogan, C., Bogen, D., Chang, J., Bodnar, L., Van Nostrand, E. (2017). Characterization of U.S. State Laws Requiring Health Care Provider Reporting of Perinatal Substance Use. Women's Health Issues, 27(3), 264-270. https://doi.org/10.1016/j.whi.2016.12.008. 4. American College of Obstetricians and Gynecologists. (2017). Opioid Use Disorder in Pregnancy. ACOG Committee Opinion. 711, 1-14. https://www.acog.org/clinical/clinical-guidance/committeeopinion/articles/2017/08/opioid-use-and-opioid-use-disorder-in-pregnancy. 5. March of Dimes. (2020). Beyond Labels. https://beyondlabels.marchofdimes.org/. 6. The National Association of County and City Health Officials. (2020). National Profile of Local Health Departments. https://www.naccho.org/uploads/downloadableresources/Programs/Public-Health-Infrastructure/NACCHO_2019_Profile_final.pdf. 7. Florida Department of Health Bureau of Vital Statistics. (2020) Births Covered by Medicaid. https://www.flhealthcharts.gov/ChartsDashboards/rdPage.aspx?rdReport=Birth.Dataview er&cid=595&drpCounty=1. 8. University of Michigan Behavioral Health Workforce Research Center and the National Council for Behavioral Health. (2019). Factors that Influence Access to MedicationAssisted Treatment. https://www.behavioralhealthworkforce.org/wpcontent/uploads/2019/10/Factors-that-Influence-MAT_Full-Report.pdf. 9. Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018m Pub L. No. 115-271. https://www.congress.gov/bill/115th-congress/house-bill/6 10. Guttmacher Institute. (2022). Substance Use During Pregnancy. https://www.guttmacher.org/state-policy/explore/substance-use-during-pregnancy 11. University of South Florida Health. (2022). Florida Perinatal Quality Collaborative.  https://health.usf.edu/publichealth/chiles/fpqc 12. Susanna Ginsburg. (2008). Colocating Health Services: A Way to Improve Coordination of Children's Health Care? The Commonwealth Fund Publication, 1153(43). https://www.commonwealthfund.org/sites/default/files/documents/___media_files_public ations_issue_brief_2008_jul_colocating_health_services__a_way_to_improve_coordinati on_of_childrens_health_care_ginsburg_colocation_issue_brief_pdf.pdf 13. Patrick, S.W., Schumacher, R.E., Benneyworth, B.D., Krans, E.E., McAllister, J.M., Davis, M.M. (2012). Neonatal abstinence syndrome and associated health care expenditures: United States, 2000–2009. Journal of American Medical Association, 307(18), 1934-1940. http://doi:10.1001/jama.2012.3951 14. Desai, R.J., Hernandez-Diaz, S., Bateman, B.T., Huybrechts, K.F. (2014). Increase in prescription opioid use during pregnancy among Medicaid-enrolled women. Obstetrics and Gynecology, 123(5), 997–1002.  http://doi.org/10.1097/AOG.0000000000000208